R A Marrie

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. ncbi Predictors of alternative medicine use by multiple sclerosis patients
    Ruth Ann Marrie
    Mellen Center for MS Treatment and Research, U10, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA
    Mult Scler 9:461-6. 2003
  2. ncbi Validation of the NARCOMS registry: diagnosis
    R A Marrie
    Department of Neurology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Mult Scler 13:770-5. 2007
  3. ncbi Drug Insight: interferon treatment in multiple sclerosis
    Ruth Ann Marrie
    Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Nat Clin Pract Neurol 2:34-44. 2006
  4. ncbi Validity of performance scales for disability assessment in multiple sclerosis
    R A Marrie
    Department of Neurology, Cleveland Clinic, Cleveland, OH, USA
    Mult Scler 13:1176-82. 2007
  5. ncbi Does multiple sclerosis-associated disability differ between races?
    R A Marrie
    Department of Neurology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Neurology 66:1235-40. 2006
  6. ncbi Changes in the ascertainment of multiple sclerosis
    R A Marrie
    Department of Neurology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Neurology 65:1066-70. 2005
  7. ncbi Validation of the NARCOMS registry: fatigue assessment
    Ruth Ann Marrie
    Mellen Center for MS Treatment and Research, U10, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Mult Scler 11:583-4. 2005
  8. ncbi Validation of the NARCOMS Registry: pain assessment
    Ruth Ann Marrie
    Mellen Center for MS Treatment and Research, Department of Neurology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Mult Scler 11:338-42. 2005
  9. ncbi Subjective cognitive complaints relate to mild impairment of cognition in multiple sclerosis
    Ruth Ann Marrie
    Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Mult Scler 11:69-75. 2005
  10. ncbi Association of fatigue and brain atrophy in multiple sclerosis
    Ruth Ann Marrie
    Department of Neurology Mellen Center, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    J Neurol Sci 228:161-6. 2005

Detail Information

Publications21

  1. ncbi Predictors of alternative medicine use by multiple sclerosis patients
    Ruth Ann Marrie
    Mellen Center for MS Treatment and Research, U10, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA
    Mult Scler 9:461-6. 2003
    ..To determine the frequency of alternative medicine use among multiple sclerosis (MS) patients, and the factors which predict such use...
  2. ncbi Validation of the NARCOMS registry: diagnosis
    R A Marrie
    Department of Neurology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Mult Scler 13:770-5. 2007
    ..We confirmed a diagnosis of MS in 98.7+/-1.3% of participants based on records review, physician survey or telephone interview, supporting the validity of the diagnoses reported by NARCOMS participants...
  3. ncbi Drug Insight: interferon treatment in multiple sclerosis
    Ruth Ann Marrie
    Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Nat Clin Pract Neurol 2:34-44. 2006
    ..There is still a need for more effective treatments, which might include new agents or combination therapies...
  4. ncbi Validity of performance scales for disability assessment in multiple sclerosis
    R A Marrie
    Department of Neurology, Cleveland Clinic, Cleveland, OH, USA
    Mult Scler 13:1176-82. 2007
    ..17, P=0.26). This study supports the criterion and construct validity of PS overall, and its mobility, hand, vision, fatigue, and bladder subscales. Further assessment of the cognitive, sensory and spasticity subscales is needed...
  5. ncbi Does multiple sclerosis-associated disability differ between races?
    R A Marrie
    Department of Neurology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Neurology 66:1235-40. 2006
    ....
  6. ncbi Changes in the ascertainment of multiple sclerosis
    R A Marrie
    Department of Neurology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Neurology 65:1066-70. 2005
    ..The authors assessed temporal trends in the delay from symptom onset to diagnosis (DONDX), and determined whether the degree of disability at diagnosis differs by year of symptom onset (YONSET), using the NARCOMS Registry...
  7. ncbi Validation of the NARCOMS registry: fatigue assessment
    Ruth Ann Marrie
    Mellen Center for MS Treatment and Research, U10, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Mult Scler 11:583-4. 2005
    ..Correlations between the PSF and spasticity, sensory and mobility PS scales were moderate, indicating convergent validity. The PSF has adequate criterion and construct validity in MS...
  8. ncbi Validation of the NARCOMS Registry: pain assessment
    Ruth Ann Marrie
    Mellen Center for MS Treatment and Research, Department of Neurology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Mult Scler 11:338-42. 2005
    ..Test-retest reliability was r = 0.84 (P < 0.0001). Responsiveness was 70.7%. The pain question is a valid self-report measure of pain in MS...
  9. ncbi Subjective cognitive complaints relate to mild impairment of cognition in multiple sclerosis
    Ruth Ann Marrie
    Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Mult Scler 11:69-75. 2005
    ..25; 1.07-1.47). Subjectively reported impairment reflects subtle declines in PSI and IM independent of mood, fatigue, and physical impairment Cognitive complaints should not be discounted due to depression...
  10. ncbi Association of fatigue and brain atrophy in multiple sclerosis
    Ruth Ann Marrie
    Department of Neurology Mellen Center, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    J Neurol Sci 228:161-6. 2005
    ..This suggests that the subjective complaint of fatigue is linked to destructive pathologic processes in RRMS patients...
  11. ncbi Environmental risk factors in multiple sclerosis aetiology
    Ruth Ann Marrie
    Mellen Center for MS Treatment and Research, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Lancet Neurol 3:709-18. 2004
    ..This review will focus on the environmental epidemiology of MS...
  12. ncbi Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis
    Ruth Ann Marrie
    Mellen Center for Multiple Sclerosis Treatment and Research, Department of Neurology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Mult Scler 9:621-6. 2003
    ..7). Cognitive impairment, a common MS manifestation, does not appear to reduce the reliability or validity of the MSQLI as a patient self-report measure of health status and quality of life...
  13. ncbi Disparities in the management of multiple sclerosis-related bladder symptoms
    R A Marrie
    Department of Neurology, Cleveland Clinic Foundation, OH 44195, USA
    Neurology 68:1971-8. 2007
    ..The bladder/bowel subscale (PSB) of PS has not been validated. It is also unknown whether ethnic or socioeconomic disparities exist in bladder care...
  14. ncbi Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis
    B A C Cree
    Multiple Sclerosis Center, Department of Neurology, University of California San Francisco, 350 Parnassus Ave, Suite 908, San Francisco, CA 94117, USA
    Neurology 63:2039-45. 2004
    ..African American (AA) individuals are thought to develop multiple sclerosis (MS) less frequently than Caucasian American (CA) individuals...
  15. ncbi Under treatment of overactive bladder symptoms in patients with multiple sclerosis: an ancillary analysis of the NARCOMS Patient Registry
    S T Mahajan
    Department of Obstetrics and Gynecology and Urology, University Hospitals Case Medical Center, Cleveland, Ohio, USA
    J Urol 183:1432-7. 2010
    ..We describe the prevalence of overactive bladder symptoms in patients with multiple sclerosis as well as the rates of evaluation and treatment of urinary complaints...
  16. ncbi Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls
    Myla D Goldman
    Department of Neurology, University of Virginia, Charlottesville, VA 22908, USA
    Mult Scler 14:383-90. 2008
    ..To assess the correlation of 6MW to subjective measures of fatigue, health status and ambulation using the modified fatigue impact scale (MFIS), short form-36 Health Questionnaire physical component score and MS walking scale (MSWS)...
  17. ncbi Functional pathway-defined MRI diffusion measures reveal increased transverse diffusivity of water in multiple sclerosis
    Mark J Lowe
    Division of Radiology, The Cleveland Clinic Foundation, 9500 Euclid Ave U15, Cleveland, OH 44195, USA
    Neuroimage 32:1127-33. 2006
    ..392, P < 0.02), indicating that probing functional pathways with MRI measures can lead to a better reflection of disease status...
  18. ncbi Resting state sensorimotor functional connectivity in multiple sclerosis inversely correlates with transcallosal motor pathway transverse diffusivity
    Mark J Lowe
    Imaging Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Hum Brain Mapp 29:818-27. 2008
    ..This constitutes the first in vivo observation of a correlation between measures of anatomic connectivity and functional connectivity using spontaneous LFBFs...
  19. ncbi When one and one make three: HLA and EBV infection in MS
    Ruth Ann Marrie
    Neurology 70:1067-8. 2008
  20. ncbi Autoimmune disease and multiple sclerosis: methods, methods, methods
    Ruth Ann Marrie
    Lancet Neurol 6:575-6. 2007
  21. ncbi You get what you measure: evaluating endpoints in MS clinical trials
    Ruth Ann Marrie
    Neurology 71:620-1. 2008